# Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders

> **NCT03123458** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Shenzhen Geno-Immune Medical Institute** · enrollment: 100 (estimated)

## Conditions studied

- Immune Related Disorder
- Tissue Damage

## Interventions

- **BIOLOGICAL:** clonal fetal MSCs

## Key facts

- **NCT ID:** NCT03123458
- **Lead sponsor:** Shenzhen Geno-Immune Medical Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03123458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03123458, "Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03123458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*